Plain-English translation of NCT07283887 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether combining two medications called and works better than using either one alone to strengthen bones in women with osteoporosis. Osteoporosis is a condition where bones become weak and more likely to break, especially after menopause. The study will compare three groups: one taking only , one taking only , and one taking both medications together.
Many women with severe osteoporosis don't improve enough with standard treatments alone. This trial is designed to see if combining two different types of bone-strengthening medications might work better, helping more women reach healthier bone density and lower their fracture risk.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to one of three groups for 6 months. Depending on your group, you'll either receive one injection of , monthly injections of , or a combination of both. Throughout the study, your doctors will monitor your bone density with scans, check blood markers to see how your bones are responding, and watch for any side effects.
AI-generated summary from trial data ยท Jun 6, 2026 ยท Not medical advice
Taiwan